A detailed history of South State Corp transactions in Viatris Inc stock. As of the latest transaction made, South State Corp holds 854 shares of VTRS stock, worth $8,873. This represents 0.0% of its overall portfolio holdings.

Number of Shares
854
Previous 480 77.92%
Holding current value
$8,873
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

BUY
$7.26 - $9.12 $2,715 - $3,410
374 Added 77.92%
854 $7,000
Q1 2025

May 12, 2025

BUY
$8.68 - $12.42 $4,166 - $5,961
480 New
480 $4,000
Q4 2024

Feb 10, 2025

BUY
$11.32 - $13.37 $0 - $0
0 New
0 $0
Q3 2024

Nov 08, 2024

BUY
$10.32 - $12.13 $0 - $0
0 New
0 $0
Q2 2024

Aug 02, 2024

BUY
$10.05 - $12.02 $0 - $0
0 New
0 $0
Q1 2024

May 06, 2024

BUY
$11.27 - $13.53 $0 - $0
0 New
0 $0
Q4 2023

Feb 06, 2024

SELL
$8.77 - $10.85 $140 - $173
-16 Closed
0 $0
Q3 2023

Nov 07, 2023

BUY
$9.59 - $11.35 $153 - $181
16 New
16 $0
Q2 2023

Aug 08, 2023

BUY
$9.02 - $10.29 $0 - $0
0 New
0 $0
Q3 2022

Nov 07, 2022

SELL
$8.48 - $11.13 $23,608 - $30,985
-2,784 Closed
0 $0
Q2 2022

Aug 05, 2022

BUY
$9.95 - $12.27 $20,327 - $25,067
2,043 Added 275.71%
2,784 $29,000
Q1 2022

May 06, 2022

BUY
$9.81 - $15.4 $6,386 - $10,025
651 Added 723.33%
741 $8,000
Q4 2021

Feb 11, 2022

BUY
$12.09 - $14.68 $1,088 - $1,321
90 New
90 $1,000
Q3 2021

Nov 10, 2021

SELL
$13.25 - $15.13 $3,604 - $4,115
-272 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$12.97 - $16.15 $19,753 - $24,596
-1,523 Reduced 84.85%
272 $4,000
Q1 2021

May 12, 2021

SELL
$13.59 - $18.54 $78,373 - $106,920
-5,767 Reduced 76.26%
1,795 $25,000
Q4 2020

Feb 10, 2021

BUY
$14.3 - $18.74 $108,136 - $141,711
7,562 New
7,562 $141,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track South State Corp Portfolio

Follow South State Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.